Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00328965 |
This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.
Condition | Intervention | Phase |
---|---|---|
Essential Hypertension |
Drug: Lacidipine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Open Label, Multi-Centre, Single Arm Phase IV Study to Evaluate the Antihypertensive Effect of Lacidipine in Mild to Moderate Essential Hypertension Patients With Type 2 Diabetes in Korea |
Estimated Enrollment: | 257 |
Study Start Date: | April 2005 |
Ages Eligible for Study: | 35 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | LAC103842 |
Study First Received: | May 22, 2006 |
Last Updated: | October 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00328965 History of Changes |
Health Authority: | South Korea: Korea Food and Drug Administration (KFDA) |
Essential hypertension Type 2 diabetes lacidipine Endothelial function Korean patients |
Essential Hypertension Metabolic Diseases Lacidipine Diabetes Mellitus Vascular Diseases Calcium Channel Blockers Endocrine System Diseases Cardiovascular Agents |
Antihypertensive Agents Calcium, Dietary Diabetes Mellitus, Type 2 Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder Hypertension |
Metabolic Diseases Lacidipine Molecular Mechanisms of Pharmacological Action Diabetes Mellitus Vascular Diseases Endocrine System Diseases Calcium Channel Blockers Cardiovascular Agents |
Antihypertensive Agents Pharmacologic Actions Membrane Transport Modulators Therapeutic Uses Diabetes Mellitus, Type 2 Cardiovascular Diseases Glucose Metabolism Disorders Hypertension |